Skip to main content

New study reveals how resveratrol might work (don’t lose your SIRT)


The latest study on resveratrol, the touted polyphenol from red wine, seems at first glance to restore some lost credibility to its increasingly questioned anti-aging capabilities. It has been widely reported but we know from experience by now that a single study never tells the whole story. The whole story would take more space than I have here so here is what you need to know:

There is a unique phenomenon called caloric restriction that extends lifespan dramatically, at least in experimental animals and organisms. By limiting caloric intake severely, a metabolic change occurs that results from activation of a family of genes know as SIRT, which code for proteins known as sirtuins. Resveratrol has been reported to activate sirtuins and thereby cause lifespan extension, at least for yeast cells, fruitflies and worms. Getting it to do the same thing in mammals such as mice and men has been problematic however, casting doubt on the use of resveratrol as a miracle anti-aging tonic. Some labs have reported that resveratrol does not in fact activate SIRT. Meanwhile, the company founded to develop resveratrol-based pharmaceuticals (Sirtris) has scrambled to maintain their case.

This latest study, from Dr. David Sinclair (cofounder of Sirtris) employed a strategy using mice with the SIRT gene “knocked out.” So by testing resveratrol’s effects in knockout vs normal mice, the role of sirtuins can be determined. What they found was that metabolic measurements were healthier in the normal mice given a high-fat diet plus resveratrol, but not the SIRT knockout mice. So resveratrol’s effects do depend on SIRT, (as well as an unhealthy diet) implying that it is a sirtuin activator after all. We are still left, however, with the question of how much this relates to human health.

Recall from previous posts here that there isn’t enough resveratrol in wine to explain the well-established health benefits including longer lifespan associated with moderate consumption. There is also the problem that resveratrol is quickly transformed after ingestion into a different molecule called piceatannol.  So before concluding that this recent study confirms that resveratrol works as a supplement, have a glass of wine and mull it over.

Comments

  1. I am very much impressed from your post.It has amazing information.I learned lot of new things which explores my knowledge in various developments.So i must appreciate your efforts on posting these information.does raspberry ketones really work |how does raspberry ketone work |raspberry ketone reviews does it work

    ReplyDelete

Post a Comment

Popular posts from this blog

Which came first: Beer or wine? (or something else?)

Actually neither beer nor wine was the first fermented beverage, and wine arguably has a closer connection to health, but recent evidence indicates that humans developed the ability to metabolize alcohol long before we were even human. The uniquely human ability to handle alcohol comes from the digestive enzyme alcohol dehydrogenase, or ADH4. A new science called paleogenetics identifies the emergence of the modern version of the ADH4 gene in our ape ancestors some 10 million years ago. Interestingly, this corresponds to the time when our arboreal forebears transitioned to a nomadic lifestyle on the ground. We went from swinging from tree limbs to walking upright, and the rest is history. Understanding the circumstances that led to perpetuation of the ADH4 mutation may contain clues to what made us human in the first place. How the ability to metabolize alcohol made us human Paleogenetecist Matthew Carrigan has an idea about how this happened . Arboreal species rely on fruit tha

Why I am not surprised that the NIH cancelled the alcohol-health study

Not long after enrolling the first patients in the much hyped prospective study on alcohol and health, the National Institutes of Health recently announced that they were pulling the plug. I am actually more surprised that they ever got it off the ground in the first place. As I wrote a year ago when the study was still in its planning stages, there were too many competing interests, criticisms of the study design, and concerns about funding to expect that whatever results came out would be universally accepted. Nevertheless, I am disappointed. The study, called Moderate Alcohol and Cardiovascular Health Trial (MACH) was intended to provide hard evidence about the health effects of moderate alcohol consumption by prospectively assigning subjects with heart disease to one drink per day or not drinking, which they were to follow for up to 10 years. Most existing data on the question is retrospective, or simply tracks a subject population according to their drinking preferences, w